CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- FinancialsAltman Z-Score 6.92: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.10%
Annual Rate
CNY 0.30Paid annual
Payout Ratio
75.0%Moderate
Payback Period
95.7 yr
Last Ex-Dividend
Jun 10, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.74BCNY408.53M · vs all stocks (USD)
Revenue (TTM)
384.50MCNY57.38M · vs all stocks (USD)
Profit Margin
-8.87%vs Medical Devices peers
Beta
0.6950xvs all stocks
52-Week Change
3.13%vs all stocks
Market Capitalization
2.74BCNY408.53M · vs all stocks (USD)
Enterprise Value
1.56BCNY232.93M · vs all stocks (USD)
Price to Sales (TTM)
7.12xvs Medical Devices peers
Price to Book (MRQ)
1.25xvs Medical Devices peers
Enterprise to Revenue
4.06xvs Medical Devices peers
Enterprise to EBITDA
17.30xvs Medical Devices peers
Gross Margin
46.85%vs Medical Devices peers
Profit Margin
-8.87%vs Medical Devices peers
Operating Margin
8.10%vs Medical Devices peers
Return on Assets (TTM)
1.28%vs Medical Devices peers
Return on Equity (TTM)
-1.65%vs Medical Devices peers
Revenue (TTM)
384.50MCNY57.38M · vs all stocks (USD)
Revenue per Share (TTM)
3.92CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-14.50%vs Medical Devices peers
Gross Profit (TTM)
187.18MCNY27.93M · vs all stocks (USD)
EBITDA (TTM)
70.52MCNY10.52M · vs all stocks (USD)
Net Income (TTM)
-34.10MCNY-5.09M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-11.00%vs Medical Devices peers
Operating Cash Flow (TTM)
99.41MCNY14.83M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-5.89MCNY-878.75K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.3000CNYUpdated Sep 20, 2026Trailing Annual Dividend Yield
1.10%vs all stocks
Payout Ratio
75.00%vs Medical Devices peers
Minority Interest (Equity)
7.25MCNYFY2025 · Dec 31, 2025Revenue
387.49MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
199.21MCNYFY2025 · Dec 31, 2025Gross Profit
188.28MCNYFY2025 · Dec 31, 2025Operating Income
54.08MCNY8.07M · vs all stocks (USD)
Pre-tax Income
-27.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
12.32MCNYFY2025 · Dec 31, 2025Net Income
-39.90MCNYFY2025 · Dec 31, 2025EBIT
-26.30MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
120.64MCNYFY2025 · Dec 31, 2025Research & Development
20.97MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
37.72MCNYFY2025 · Dec 31, 2025Other Operating Expenses
5.66MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
671.58KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.27MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.3800CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.3800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
99.84MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
99.84MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-39.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
1.96MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-27.72MCNYFY2025 · Dec 31, 2025Free Cash Flow
-73.72MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
78.41MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-39.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
1.80MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
18.61MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-8.23MCNYFY2025 · Dec 31, 2025Capital Expenditures
-45.99MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.66BCNYFY2025 · Dec 31, 2025Sale of Investments
2.56BCNYFY2025 · Dec 31, 2025Other Investing Activity
-36.27KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-147.05MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
144.45MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-61.56MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-60.42MCNYFY2025 · Dec 31, 2025Other Financing Charges
1.64MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
24.11MCNYFY2025 · Dec 31, 2025Shares Outstanding
100.17MSharesUpdated Sep 20, 2026Float Shares
58.26MSharesUpdated Sep 20, 2026% Held by Insiders
46.76%vs all stocks
% Held by Institutions
4.75%vs all stocks
Total Cash (MRQ)
1.25BCNY186.86M · vs all stocks (USD)
Total Cash per Share (MRQ)
12.69CNYUpdated Sep 20, 2026Total Debt (MRQ)
109.89MCNY16.40M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0509xvs Medical Devices peers
Current Ratio (MRQ)
7.08xvs Medical Devices peers
Book Value per Share (MRQ)
21.81CNYUpdated Sep 20, 2026Total Assets
2.43BCNY362.43M · vs all stocks (USD)
Total Current Assets
1.48BCNYFY2025 · Dec 31, 2025Total Liabilities
274.04MCNYFY2025 · Dec 31, 2025Total Non-current Assets
945.89MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
15.44MCNYFY2025 · Dec 31, 2025Total Current Liabilities
258.60MCNYFY2025 · Dec 31, 2025Cash
78.41MCNYFY2025 · Dec 31, 2025Cash Equivalents
0.00CNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
78.41MCNYFY2025 · Dec 31, 2025Other Short-term Investments
1.20BCNYFY2025 · Dec 31, 2025Accounts Receivable
79.95MCNYFY2025 · Dec 31, 2025Inventory
114.07MCNYFY2025 · Dec 31, 2025Accounts Payable
102.96MCNYFY2025 · Dec 31, 2025Short-term Debt
116.45MCNYFY2025 · Dec 31, 2025Other Current Liabilities
3.40MCNYFY2025 · Dec 31, 2025Long-term Debt
1.51MCNYFY2025 · Dec 31, 2025Common Stock (Book)
100.17MCNYFY2025 · Dec 31, 2025Retained Earnings
333.47MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
2.15BCNY321.54M · vs all stocks (USD)
Treasury Stock
29.99MCNYFY2025 · Dec 31, 202552-Week Low
21.60CNYUpdated Sep 20, 202652-Week High
37.08CNYUpdated Sep 20, 202652-Week Change
3.13%vs all stocks
Beta
0.6950xvs all stocks
50-Day MA
27.26CNYUpdated Sep 20, 2026200-Day MA
28.16CNYUpdated Sep 20, 2026Avg 10-Day Volume
1.20MSharesUpdated Sep 20, 2026Avg 30-Day Volume
1.64MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.3300CNYUpdated Sep 20, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.47Profit Margin: -0.09
Financial Health
Altman Z-Score 6.92: safe zoneNotable
Altman Z-Score: 6.92
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Relmada Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Aarti Drugs Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kamada Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Grape King Bio Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Yantai Zhenghai Bio-Tech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Tellgen Corporation
Tier 1ProductionApproval-Gated PipelineRule
Ars Pharmaceuticals Inc
Tier 1ProductionApproval-Gated PipelineRule
Hubei Goto Biopharm Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
AP Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Atea Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule